|
|
News Breaks | | | | January 25, 2013 | | 07:59 EDT |  | VPHM | Concerns over ViroPharma competition overblown, says Oppenheimer
After meeting with ViroPharma investors, Oppenheimer believes that investors are concerned about potential competition for the company in the prophylactic space. The firm, however, thinks this concern is overblown, given what it sees as under-appreciated hurdles for U.S. approval of competitive products. The firm maintains an Outperform rating on the stock. | |
|
News For VPHM From The Last 14 Days Check below for free stories on VPHM the last two weeks. |
|
|
| There are no results for VPHM |
|
|
|
|
|
|
